胱抑素C对急性冠脉综合征PCI术预后判断.docVIP

胱抑素C对急性冠脉综合征PCI术预后判断.doc

  1. 1、本文档共3页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
胱抑素C对急性冠脉综合征PCI术预后判断

胱抑素C对急性冠脉综合征PCI术预后判断【摘要】目的 探讨血浆胱抑素C(cystatin C,CysC)水平对急性冠脉综合征(acute coronary syndromes,ACS)患者经皮冠状动脉介入(percutanceous coronary intervention,PCI)术后预后的判断价值。方法 连续选取2009年9月至2010年6月于郑州大学第一附属医院心内科住院的ACS患者660例为研究对象。入选标准:冠脉造影显示至少一支血管狭窄程度为75%以上,成功接受PCI手术治疗,且肾功能正常或存在轻度肾功能不全[肾小球滤过率(GFR)60 ml/(min?1.73 m2)]。排除标准:严重肝肾功能损伤或患有肿瘤、心脏瓣膜病。记录患者入院24 h内血浆CysC浓度(乳胶增强免疫比浊法)及其他临床资料。于2011年3月至7月进行门诊和电话随访,记录心脏不良事件的发生情况。根据CysC四分位数将患者分为4组:Q1(CysC60 ml/(min?1.73 m2). Exclusion criteria were severe liver and renal insufficiency, malignancies and valvular heart diseases. The plasma CysC levels were examined by the latex enhanced immune turbidity method within 24 hours after admission. The relevant clinical data were recorded. The patients were followed up by out-patient interview or telephone from March to June 2011 and adverse cardiovascular events were recorded. The patients were divided into four groups according to CysC level: Q1 (CysC1.02 mg/L), Q2 (1.02 mg/L≤CysC 1.17 mg / L), Q3 (1.17 mg/L ≤ CysC 1.35 mg/L) and Q4 (CysC≥1.35 mg/L). Univariate and multivariate Cox hazards regressions were established to analyze the factors related to prognosis. The proportion differences between four groups were tested by χ2. The survival ratio was estimated using the Kaplan-Meier method. Statistical significance was established at a P value of less than 0.05.Results ① A total of 606 (91.7%) patients successfully accepted follow-up. Mean follow-up time was (14.3±1.7) months. Of them, 95 patients were subjected to adverse cardiovascular events (15.7%). ②The incidences of adverse cardiovascular events in Q2, Q3, Q4 were significantly higher than those in Q1 (P0.001). The rates of mortality, nonfatal myocardial infarction and target lesion revascularization in Q4 were higher than those in Q1 (P0.05). The incidences of heart failure in Q3 and Q4 were higher than that in Q1 (P0.05). ③Univariate analysis demonstrated that CysC, creatinine, LVEF, age, history of PCI and NYHA grade ≥3 were the risk factors of poor pr

文档评论(0)

linsspace + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档